Oxford Cancer Analytics

oxford cancer analytics ltd has developed decancer.ai, an artificial intelligence-based platform that can detect the deadliest cancers early to enable curative treatments. decancer.ai's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. oxford cancer analytics hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. it is safer, cheaper, and detects cancers much earlier, when they are still curable. p.liu@oxcan.org and a.halner@oxcan.org